UPDATE: Trump Accepts Hamas' Claims of Cooperation on Gaza Peace Plan
VA Dem Attorney General Candidate Wished Death on GOP Lawmakers
Hamas Just Made a Major Announcement on the Gaza War, But Will They...
Justice Kavanaugh's Would-Be Assassin Gets Light Sentence Because of His Trans Identity
Britain's Soft-on-Crime Policies Allowed the Manchester Synagogue Terror Attack to Happen
'This Is a Big Day:' President Trump Speaks About Hamas Agreement to Release...
Sen. Josh Hawley Says He's 'Baffled' by FDA's Approval of Another Abortion Drug
Hollywood Hates Censorship but Won't Act, The Atlantic Idiotically Compares Charlie Kirk t...
UK Home Secretary Shabana Mahmood Says She's 'Surprised' by Name of Manchester Synagogue...
Broadview Police Chief Ready to Tear Down Fence Around ICE Facility
Equity: Zohran Mamdani Will Eliminate Gifted Programs From NYC Schools
Sean 'Diddy' Combs Sentenced to 4 Years, 2 Months for Prostitution-Related Crimes
Illegal Alien with 30-Year Rap Sheet Ran Iowa School District
WATCH: Tim Walz Explains 2024 Loss With Wild Debate Excuse
Cancel Netflix: Conservative Leaders Call Out Alleged Radical Agenda
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement